Mao-Lin Yan

Fujian Provincial Hospital

Papers

1

Total Citations

20

H-Index

1

About

Dr. Mao-Lin Yan is a leading hepatobiliary surgeon whose research focuses on advancing surgical techniques for hepatocellular carcinoma (HCC), particularly through the comparison of robotic and open hepatectomy. His major contributions lie in demonstrating the safety and efficacy of minimally invasive approaches for complex liver tumors, challenging conventional surgical boundaries. In a landmark 2023 multicenter study, Dr. Yan and his team showed that robotic hepatectomy offers significant short-term benefits—including reduced blood loss and shorter hospital stays—without compromising long-term oncologic outcomes for patients with large HCC, a population often deemed high-risk for robotic surgery. This work, already garnering over 20 citations, has helped reshape clinical decision-making for large liver tumors. Dr. Yan’s research is notable for its rigorous methodology and direct impact on surgical practice, providing evidence that robotic techniques can extend their advantages to challenging cases. His ongoing investigations continue to refine patient selection and optimize surgical strategies, making him a key voice in the evolution of minimally invasive liver surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Fujian Provincial Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago